HYDROCORTISONE VALE

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS Pharmaceutical Group Inc, with CAGE code 1UNB0, for the procurement of 2 treatment units of HYDROCORTISONE VALE, identified by NSN 6505010939901, at a total contract value of $19.46. The award was issued on July 14, 2026, with a required delivery date of July 29, 2026, to Fort Bragg, North Carolina, under FOB destination terms where the contractor assumes all transportation costs and risks until acceptance by the government at the destination. The item is procured under a small business set-aside, with the awardee certified as a small, small disadvantaged, and women-owned business, triggering compliance with federal small business program requirements including potential reporting obligations. Payment will be processed by the Defense Finance and Accounting Service via a D.O. voucher, with remittance sent to a Columbus, Ohio address. The contractor must ensure all packaging and labeling conform to government specifications, including marking each package with the contract and delivery order numbers and the “MARKFOR” shipping address using block printing, while parcel post is explicitly prohibited. Inspection and acceptance are solely the responsibility of the government upon delivery, and the contract does not specify external quality standards, relying instead on adherence to the basic contract’s terms and Department of Defense pharmaceutical protocols. Primary administrative oversight is handled by DLA Troop Support’s Medical Supply Chain team in Philadelphia, with Lisa Quinn serving as the ordering officer and Shairy M. Cartagena as the local contact. No additional clauses, attachments, special requirements, or evaluation factors beyond the basic contract terms are detailed in the award documentation, which consists solely of this single-line-item delivery order for an essential pharmaceutical product.